Moreno Curti

Moreno Curti

Auto-generated profile, based on publicly available information

Moreno Curti

Istituto di Anatomia Patologica, IRCCS Policlinico San Matteo, Pavia

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2011 in European Journal of Heart Failure
Verified
Journal Article
Closed access
PDF file
CKCatherine Marie Klersy
Catherine Marie Klersy
ASannalisa de silvestri
annalisa de silvestri
GGGabriella Gabutti
Gabriella Gabutti
ARArturo Raisaro
Arturo Raisaro
MCMoreno Curti
Moreno Curti
AAAngelo Auricchio
Angelo Auricchio
Aims: To assess the cost-effectiveness and the cost utility of remote patient monitoring (RPM) when compared with the usual care approach based upon differences in the number of hospitalizations, estimated from a meta-analysis of randomized clinical trials (RCTs). Methods and results: We reviewed the literature published between January 2000 and September 2009 on multidisciplinary heart failure (HF) management, either by usual care or RPM to retrieve the number of hospitalizations and length of stay (LOS) for HF and for any cause. We performed a meta-analysis of 21 RCTs (5715 patients). Remote patient monitoring was associated with a significantly lower number of hospitalizations for HF [incidence rate ratio (IRR): 0.77, 95% CI 0.65–0.91, P < 0.001] and for any cause (IRR: 0.87, 95% CI: 0.79–0.96, P = 0.003), while LOS was not different. Direct costs for hospitalization for HF were approximated by diagnosis-related group (DRG) tariffs in Europe and North America and were used to populate an economic model. The difference in costs between RPM and usual care ranged from €300 to €1000, favouring RPM. These cost savings combined with a quality-adjusted life years (QALYs) gain of 0.06 suggest that RPM is a ‘dominant’ technology over existing standard care. In a budget impact analysis, the adoption of an RPM strategy entailed a progressive and linear increase in costs saved. Conclusions: The novel cost-effectiveness data coupled with the demonstrated clinical efficacy of RPM should encourage its acceptance amongst clinicians and its consideration by third-party payers. At the same time, the scientific community should acknowledge the lack of prospectively and uniformly collected economic data and should request that future studies incorporate economic analyses.

28 January 2022 in European Heart Journal
Verified
Journal Article
Closed access
GBGiovanni Benfari
Giovanni Benfari
PSPaul Sorajja
Paul Sorajja
GPGiovanni Pedrazzini
Giovanni Pedrazzini
MTMaurizio Taramasso
Maurizio Taramasso
MGMara Gavazzoni
Mara Gavazzoni
MEMaurice Enriquez-Sarano
Maurice Enriquez-Sarano
Background: Randomized clinical trials demonstrated transcatheter edge-to-edge repair (TEER) efficacy in improving outcome vs. medical management for functional mitral regurgitation, but limited randomized data are available for the treatment of degenerative mitral regurgitation (DMR). We aimed to compare the outcome of older patients treated with TEER vs. unoperated DMR. Methods and results: Registries including consecutive patients ≥65 years with symptomatic severe DMR treated with TEER (MitraSwiss and Minneapolis Heart Institute registries) or unoperated (MIDA registry) were analysed. Survival was compared overall and after matching for age, sex, EuroSCORE II, and ejection fraction. The study included 1187 patients (872 treated with TEER and 315 unoperated). During 24 ± 17 months of follow-up, 430 patients died, 18 ± 1% at 1 year and 50 ± 2% at 4 years. Patients undergoing TEER had similar age (82 ± 6 vs. 82 ± 7 years) and sex to unoperated patients, but higher surgical risk/comorbidity (EuroSCORE II 3.98 ± 4.28% vs. 2.77 ± 2.46%), more symptoms, and atrial fibrillation (P < 0.0001). Transcatheter edge-to-edge repair was associated with lower mortality accounting for age, sex, EuroSCORE II, New York Heart Association class, atrial fibrillation, and ejection fraction [hazard ratio (HR): 0.47, 95% confidence interval (CI): 0.37–0.58; P < 0.0001]. After propensity matching (247 pairs of patients), TEER consistently showed better survival compared with unoperated patients (49 ± 6% vs. 37 ± 3% at 4 years, P < 0.0001) even in comprehensive multivariable analysis (HR: 0.60, 95% CI: 0.40–0.91; P = 0.03). Procedural failure was infrequent but post-procedural mitral regurgitation, remaining moderate-to-severe in 66 (7.6%) patients, was associated with excess mortality vs. trivial residual regurgitation (30 ± 6% vs. 11 ± 1% at 1 year, P < 0.0001). Conclusion: Amongst older patients with severe symptomatic DMR at high surgical risk, mitral TEER was associated with higher survival vs. unoperated patients. Successful control of mitral regurgitation was key to survival improvement with mitral TEER, which should be actively considered in patients deemed inoperable.

1 December 2013 in International Journal of Cardiology
Verified
Journal Article
Closed access
CKCatherine Marie Klersy
Catherine Marie Klersy
MFMarco Ferlini
Marco Ferlini
ARArturo Raisaro
Arturo Raisaro
VSValeria Scotti
Valeria Scotti
ABAnna Balduini
Anna Balduini
ASannalisa de silvestri
annalisa de silvestri

10 June 2010 in Heart
Verified
Journal Article
Closed access
PDF file
Francesco Fulvio FaletraFrancesco Fulvio Faletra
Francesco Fulvio Faletra
IDI D'ANgeli
I D'ANgeli
CKCatherine Marie Klersy
Catherine Marie Klersy
MAM Averaimo
M Averaimo
JKJ Klimusina
J Klimusina
AAA Auricchio
A Auricchio
Aims: To estimate the life attributable risk (LAR) of cancer incidence over a wide range of dose radiation exposure and a large spectrum of possible diagnostic computed tomographic coronary angiography (CTCA) scenarios. Methods: This study included 561 consecutive patients who underwent a successful prospective ECG-gating CTCA protocol (low-dose group) 64-slice CTCA and 188 patients who underwent retrospective ECG-gating CTCA with ECG-triggered dose modulation CTCA (high-dose group). LAR was computed, given the organ equivalent dose, for all cancers in both sexes. LAR was tabulated for each decile of dose-length product by 10-year age classes, separately for each sex. Results: Estimates of LAR of any cancer for an exposure at age ≤40 year were lower in males than in females for any given quantile. At age ≥50years, LAR was similar between sexes only at the lowest exposure doses, whereas at higher dosage, it was, in general, higher for women. At the median age of this case series (62 years) and for a radiation exposure ranging from 1.33 to 3.81 mSv, LAR was 1 in 4329 (or 23.1 per 105 persons exposed) and 1 in 4629 (or 21.6 per 105 persons) in men and women, respectively. For an exposure ranging from 10.34 to 18.97 mSv at the same median age, the LAR of cancer incidence was 1 in 1336 (or 74.8 per 105 persons) in men and doubled (1 in 614 or 162.8 per 105 persons) in women. Conclusions: This study provided an estimate of the LAR of cancer in middle-aged patients of both sexes after a single diagnostic CTCA, providing an easy-to-read table.

1 October 2016 in The International Journal of Biological Markers
Verified
Journal Article
Open access
VSValeria Scotti
Valeria Scotti
ASannalisa de silvestri
annalisa de silvestri
LSLuigia Scudeller
Luigia Scudeller
PAPaola Abele
Paola Abele
FTFunda Topuz
Funda Topuz
MCMoreno Curti
Moreno Curti
Introduction: Novel bibliometric indexes (commonly known as altmetrics) are gaining interest within the scientific community and might represent an important alternative measure of research quality and output. Aims: We evaluate how these new metrics correlate with established bibliometric indexes such as the impact factor (IF), currently used as a measure of scientific production as well as a criterion for scientific research funding, and how they might be helpful in assessing the impact of research. Methods: We calculated altmetrics scores for all the articles published at our institution during a single year and examined the correlation between altmetrics scores and IFs as a measure of research quality and impact in all departments. Results: For all articles from the various departments published in a single year, the altmetrics score and the sum of all IFs showed a strong and significant correlation (Spearman's rho 0.88). The correlation was significant also when the major components of altmetrics, including Facebook, Twitter and Mendeley, were analyzed. The implementation of altmetrics has been found to be easy and effective at both the researcher and librarian levels. Conclusions: The novel bibliographic index altmetrics is consistent and reliable and can complement or be considered a valid alternative to standard bibliometric indexes to benchmark output and quality of research for academic and funding purposes.

1 February 2017 in International Journal of Cardiology
Verified
Journal Article
Closed access
MCMaria Luce Caputo
Maria Luce Caputo
FRFrançois Regoli
François Regoli
GCGiulio Conte
Giulio Conte
BABoris Adjibodou
Boris Adjibodou
SSStefano Svab
Stefano Svab
AAAngelo Auricchio
Angelo Auricchio